Skip to content
Open access

Machine Learning-Based Prediction And Long-Term Validation Of Colorectal Carcinoma Risk: A Generalizability Study Across Demographically Diverse Populations

Nov 2026 · Computer and Decision Making: An International Journal · 0 citations

Abstract

Colorectal carcinoma ranks third globally in cancer incidence and second in cancer-related mortality, with approximately 935,000 deaths recorded in 2020. Despite advancements in screening through colonoscopy and improved follow-up treatments, many patients continue to receive diagnoses at advanced stages, particularly across lower and middle-income regions. This study presents a machine learning system designed to estimate CRC likelihood, addressing two overlooked issues: absent extended time-frame testing and limited proof of broad applicability. A dataset of 5,430 patient records was assembled from 4 independent institutional cohorts and 6 demographic subgroups. Five classification algorithms were developed and systematically assessed: Logistic Regression, Naive Bayes, Support Vector Machine, Random Forest, and XGBoost. XGBoost achieved superior performance with an AUC-ROC of 0.961, accuracy of 94.3%, and F1-score of 0.939 on the primary test set. Longitudinal validation from 2018 to 2024 demonstrated that XGBoost maintained AUC-ROC values above 0.945 in each year, confirming sustained predictive durability. Validation across seven distinct populations — Caucasian, East Asian, South Asian, African, Hispanic, Middle Eastern, and others — yielded AUC-ROC scores ranging from 0.935 to 0.961, each exceeding the 0.90 minimal clinical threshold for model robustness. The framework provides both a high-performance predictive model and a repeatable methodological template for clinically validating ML models with demonstrated longevity.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.